Mariana Oncology is a radiopharmaceutical company that aims to treat tumors and advance cancer treatment technology. With a mission to revolutionize radio cancer medicine, Mariana Oncology targets specific organs without damaging normal, healthy tissue. Other features of the company include therapeutic radioisotopes, physicochemical multiparameter optimization, and their radio-conjugation platform. Mariana Oncology was founded by Simon Read in 2021 and is headquartered in Boston, MA.

Register for Details

For more details on financing and valuation for Mariana Oncology, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Mariana Oncology

Forge green plus iconForge green minus icon

Is Mariana Oncology a publicly traded company?

Mariana Oncology is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

What is Mariana Oncology's IPO price?

The IPO price for Mariana Oncology will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Mariana Oncology pre-IPO?

Mariana Oncology is privately held company and is not publicly traded, therefor investing in Mariana Oncology pre-IPO is only available to accredited investors. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to invest in private companies before their potential IPO. If you are not an accredited investor, discover how to begin the the process to potentially qualify for new investment opportunities.

Forge green plus iconForge green minus icon

What is the value of my Mariana Oncology shares?

To determine the value of your Mariana Oncology shares, create a free account to gain access to Forge’s platform. Forge Markets contains pricing information for hundreds of pre-IPO companies. A Private Market Specialist will also be available to assist you with any inquiries related to your Mariana Oncology shares. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Can you sell Mariana Oncology before it goes public?

Yes, you can seek to sell shares in Mariana Oncology while it remains private. If you are considering selling, you can register today for free to get started. Once registered, a Private Market Specialist will guide you through any questions you might have. You may also continue to browse through our resources to help you understand the implications and procedures involved in selling your private market shares.

Forge green plus iconForge green minus icon

What is Mariana Oncology's funding to date?

Mariana Oncology has raised $250MM to date.
Forge green plus iconForge green minus icon

When was Mariana Oncology founded?

Mariana Oncology was founded in 2021.

Mariana Oncology funding rounds and last known valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
9/7/2023

Series B

$175MM raised $XXX.XX $XXX.XX
12/1/2021

Series A

$75MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.